Wondering where all that data we collect goes? Have a look at the newest publications using BSRBR-RA data:
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register
There are also lay summaries available for many of our publications which provide a more accessible overview. Lay summaries and details of BSRBR-RA publications can be found on our research page.
